A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS

Area of Science:

• Mitochondrial biology
• Neurogenetics

Background:

• Mutations in the *CHCHD10* gene are associated with amyotrophic lateral sclerosis (ALS).
• The precise mechanisms by which *CHCHD10* mutations cause ALS remain largely unknown.
• Understanding the cellular impact of these mutations is crucial for developing therapeutic interventions.

Purpose of the Study:

• To investigate the pathogenicity of a novel *CHCHD10* mutation (Q108P) found in a patient with rapidly progressing ALS.
• To elucidate the role of the coiled-coil-helix-coiled-coil-helix (CHCH) domain in CHCHD10 mitochondrial import.
• To explore potential therapeutic targets for CHCHD10-related ALS.

Main Methods:

• Patient-derived mutation analysis (Q108P) and comparison with known pathogenic variants.
• Cellular localization studies using wild-type and mutant CHCHD10 proteins.
• Mitochondrial import assays and protein stability assessments.
• Truncation experiments to identify key functional domains.
• Mia40 knockdown and overexpression studies to assess its role in CHCHD10 import and disulfide bond formation.

Main Results:

• The novel CHCHD10 Q108P mutation significantly impaired mitochondrial import, causing cytoplasmic mislocalization and reduced protein stability.
• Other patient-derived CHCHD10 variants exhibited either impaired import or mitochondrial clustering.
• Mitochondrial import of CHCHD10 appears to be mediated by its CHCH domain, not an N-terminal signal sequence.
• Mia40, a protein involved in disulfide bond formation, is essential for CHCHD10 mitochondrial import, and its overexpression can rescue the import defect caused by the Q108P mutation.

Conclusions:

• Impaired mitochondrial import of CHCHD10 due to CHCH domain mutations is a likely mechanism driving aggressive ALS.
• The CHCH domain is critical for CHCHD10 mitochondrial targeting and import.
• Mia40 upregulation represents a potential therapeutic strategy for CHCHD10-related ALS by restoring mitochondrial function.